Random Start Ovarian Stimulation

Overview

Journal J Hum Reprod Sci

Date 2022 Aug 5

PMID 35928466

Authors

Pratap Kumar

Shubha Rao

Anjali Mundkur

Prashanth Adiga

Vidyashree G Poojari

Rashmi K Ullagaddi

Affiliations

Soon will be listed here.

Abstract

Fertility preservation is emerging in recent years as an important option for various indications many of which being for cancer patients and for certain benign conditions as well. In the present case report, we set out to utilise the same protocol, however, for different indications.

References

von Wolff M, Thaler C, Frambach T, Zeeb C, Lawrenz B, Popovici R . Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2008; 92(4):1360-1365. DOI: 10.1016/j.fertnstert.2008.08.011. View

Bedoschi G, Albuquerque F, Ferriani R, Navarro P . Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet. 2010; 27(8):491-4. PMC: 2941583. DOI: 10.1007/s10815-010-9429-0. View

Letourneau J, Ebbel E, Katz P, Oktay K, McCulloch C, Ai W . Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer. 2011; 118(7):1933-9. PMC: 3220922. DOI: 10.1002/cncr.26403. View

Bleicher R, Ruth K, Sigurdson E, Ross E, Wong Y, Patel S . Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012; 30(36):4485-92. PMC: 3518727. DOI: 10.1200/JCO.2012.41.7972. View

Courbiere B, Decanter C, Bringer-Deutsch S, Rives N, Mirallie S, Pech J . Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study. Hum Reprod. 2013; 28(9):2381-8. DOI: 10.1093/humrep/det268. View

Baerwald A, Adams G, Pierson R . Characterization of ovarian follicular wave dynamics in women. Biol Reprod. 2003; 69(3):1023-31. DOI: 10.1095/biolreprod.103.017772. View

Cai H, Shen H . Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report. Braz J Med Biol Res. 2016; 49(6):e5227. PMC: 4869827. DOI: 10.1590/1414-431X20165227. View

Letourneau J, Sinha N, Wald K, Harris E, Quinn M, Imbar T . Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer. Hum Reprod. 2017; 32(10):2123-2129. DOI: 10.1093/humrep/dex276. View

Cakmak H, Katz A, Cedars M, Rosen M . Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013; 100(6):1673-80. DOI: 10.1016/j.fertnstert.2013.07.1992. View

10.

Baynosa J, Westphal L, Madrigrano A, Wapnir I . Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg. 2009; 209(5):603-7. DOI: 10.1016/j.jamcollsurg.2009.08.006. View

11.

Giacalone P, Laffargue F, Benos P, Dechaud H, Hedon B . Successful in vitro fertilization-surrogate pregnancy in a patient with ovarian transposition who had undergone chemotherapy and pelvic irradiation. Fertil Steril. 2001; 76(2):388-9. DOI: 10.1016/s0015-0282(01)01895-7. View

12.

Gagliato D, Gonzalez-Angulo A, Lei X, Theriault R, Giordano S, Valero V . Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol. 2014; 32(8):735-44. PMC: 3940536. DOI: 10.1200/JCO.2013.49.7693. View

13.

Partridge A, Gelber S, Gelber R, Castiglione-Gertsch M, Goldhirsch A, Winer E . Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer. 2007; 43(11):1646-53. DOI: 10.1016/j.ejca.2007.04.006. View

14.

Tarlatzis B, Fauser B, Kolibianakis E, Diedrich K, Rombauts L, Devroey P . GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update. 2006; 12(4):333-40. DOI: 10.1093/humupd/dml001. View

15.

Tham Y, Sexton K, Weiss H, Elledge R, Friedman L, Kramer R . The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol. 2007; 30(2):126-32. DOI: 10.1097/01.coc.0000251398.57630.4f. View

16.

Bines J, Oleske D, Cobleigh M . Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996; 14(5):1718-29. DOI: 10.1200/JCO.1996.14.5.1718. View

17.

Anderson R, Kinniburgh D, Baird D . Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment. Hum Reprod. 1999; 14(10):2665-8. DOI: 10.1093/humrep/14.10.2665. View

18.

Meniru G, Craft I . Experience with gestational surrogacy as a treatment for sterility resulting from hysterectomy. Hum Reprod. 1997; 12(1):51-4. DOI: 10.1093/humrep/12.1.51. View

19.

Deshpande N, Braun I, Meyer F . Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: A systematic review. Cancer. 2015; 121(22):3938-47. DOI: 10.1002/cncr.29637. View

20.

Sonmezer M, Turkcuoglu I, Coskun U, Oktay K . Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011; 95(6):2125.e9-11. DOI: 10.1016/j.fertnstert.2011.01.030. View